‹ All Posts
Ankit Gupta

6th Apr · SEBI-Registered Analyst

AUROPHARMA
: CO APPROVES ₹800 CRORE BUYBACK OF UP TO 54.2 LAKH SHARES AT ₹1,475 EACH.

#WatchOutFor
491 likes·70 comments